Plasma levels of oxidized low density lipoprotein are associated with stable angina pectoris and modalities of acute coronary syndrome.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  International Heart Journal

• Publication date

  2008-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1536/IHJ.49.515PMID 18971563
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated plasma levels of oxidized low-density lipoprotein relate to the presence of angiographically detected complex and thrombotic coronary artery lesion morphology in patients with unstable angina

  2008cited by this paper
• Elevated plasma levels of oxidized low-density lipoprotein relate to the presence of angiographically detected complex and thrombotic coronary artery lesion morphology in patients with unstable angina.

  2007cited by this paper
• Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.

  2004cited by this paper
• Elevated Levels of Oxidized Low Density Lipoprotein Show a Positive Relationship With the Severity of Acute Coronary Syndromes

  2001cited by this paper
• Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.

  2001cited by this paper
• Circulating Oxidized Low Density Lipoprotein Levels: A Biochemical Risk Marker for Coronary Heart Disease

  2000cited by this paper
• Is oxidized low-density lipoprotein present in vivo?

  1998cited by this paper
• Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease.

  1998cited by this paper
• Deposition of oxidized low‐density lipoprotein and collagenosis occur coincidentally in human coronary stenosis: an immunohistochemical study of atherectomy

  1998cited by this paper
• Angiotensin, LDL peroxidation and atherosclerosis.

  1998cited by this paper
• Low Density Lipoprotein Oxidation and Its Pathobiological Significance*

  1997cited by this paper
• Angiotensin II Increases Macrophage-mediated Modification of Low Density Lipoprotein via a Lipoxygenase-dependent Pathway*

  1997cited by this paper
• Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.

  1996cited by this paper
• Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes.

  1996cited by this paper
• Oxidized lipoproteins in atherosclerosis and thrombosis

  1994cited by this paper
• Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II.

  1994cited by this paper
• A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides.

  1994cited by this paper
• Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk.

  1993cited by this paper
• Vitamin E consumption and the risk of coronary disease in women.

  1993cited by this paper
• Vitamin E consumption and the risk of coronary heart disease in men.

  1993cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper
• Role of oxidised low density lipoprotein in atherogenesis.

  1993cited by this paper
• Autoantibody against oxidised LDL and progression of carotid atherosclerosis.

  1992cited by this paper
• Role of oxidized low density lipoprotein in atherogenesis.

  1991cited by this paper
• Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

  1989cited by this paper
• Low density lipoprotein undergoes oxidative modification in vivo.

  1989cited by this paper
• Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

  1989cited by this paper
• Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.

  1987cited by this paper
• Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.

  1987cited by this paper
• The thrombolysis in myocardial infarction (TIMI) trial.

  1985cited by this paper
• Influence of coronary collateral blood flow on the development of exertional ischemia and Q wave infarction in patients with severe single-vessel disease.

  1985cited by this paper
• The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

  1985cited by this paper

• Radical Oxygen Species, Oxidized Low-Density Lipoproteins, and Lectin-like Oxidized Low-Density Lipoprotein Receptor 1: A Vicious Circle in Atherosclerotic Process

  2024cites this paper
• Oxidized Low-Density Lipoprotein Decreases the Survival of Bone Marrow Stem Cells via Inhibition of Bcl-2 Expression

  2024cites this paper
• Oxidised Low-Density Lipoprotein-Induced Platelet Hyperactivity—Receptors and Signalling Mechanisms

  2022cites this paper
• Association between Circulating Oxidized OxLDL/LDL-C Ratio and the Severity of Coronary Atherosclerosis, Along With Other Emerging Biomarkers of Cardiovascular Disease in Patients With Type 2 Diabetes.

  2022cites this paper
• Association of circulating oxidized LDL-C/LDL-C ratio with severity of coronary atherosclerosis and other emerging biomarkers of cardiovascular disease in patients with type 2 diabetes

  2021cites this paper
• Structure and Dynamics of Oxidized Lipoproteins In Vivo: Roles of High-Density Lipoprotein

  2021cites this paper
• Antioxidant status and risk of coronary artery disease

  2019cites this paper
• The Significance of Oxidized Low-Density Lipoprotein in Body Fluids as a Marker Related to Diseased Conditions.

  2019cites this paper
• N‐acetylcysteine prevents oxidized low‐density lipoprotein‐induced reduction of MG53 and enhances MG53 protective effect on bone marrow stem cells

  2019cites this paper
• Association of Circulating Oxidized Lipids with Cardiovascular Outcomes

  2018cites this paper
• Dyslipidemia-associated atherogenic oxidized lipids induce platelet hyperactivity through phospholipase Cγ2-dependent reactive oxygen species generation

  2018cites this paper
• Effect of regular exercise with different intensities on oxidized LDL levels in obese men

  2018cites this paper
• Dyslipidemia in Metabolic Syndrome: an Overview of Lipoprotein- Related Disorders

  2017cites this paper
• Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases

  2015cites this paper
• The polyphenol PGG enhances expression of SR-BI and ABCA1 in J774 and THP-1 macrophages.

  2015cites this paper
• Oxidized low-density lipoprotein alters endothelial progenitor cell populations.

  2015cites this paper
• Cell membrane damage is involved in the impaired survival of bone marrow stem cells by oxidized low-density lipoprotein

  2014cites this paper
• Absence of clinical relationship between oxidized low density lipoproteins and diabetic peripheral neuropathy: a case control study

  2014cites this paper
• In vitro oxidation of LDL by ozone.

  2014cites this paper
• Novel risk factors related to stable angina.

  2013cites this paper
• Inflammatory biomarkers for predicting cardiovascular disease.

  2013cites this paper
• Using new cut-off for lipidic parameters to predict development of affected arteries in patients with acute coronary syndrome

  2013cites this paper
• In search for novel biomarkers of acute coronary syndrome.

  2012cites this paper
• The HDL proteome in acute coronary syndromes shifts to an inflammatory profile.

  2012cites this paper
• Hydroxysafflor yellow A suppresses oxidized low density lipoprotein induced proliferation of vascular smooth muscle cells

  2012cites this paper
• Traditional and Novel Risk Factors in Atherothrombosis

  2012cites this paper
• Role of Reactive Oxygen Species Formation from Oxidized Low Density Lipoprotein in Bone Marrow Stem Cells

  2012cites this paper
• Biomarcadores cardíacos: presente y futuro Cardiac biomarkers: present and future

  2012cites this paper
• Oxidized low density lipoprotein, stem cells, and atherosclerosis

  2012cites this paper
• Cholesterol-rich low density lipoproteins are also more oxidized

  2011cites this paper
• Cholesterol-rich low density lipoproteins are also more oxidized Vadim LankinMargus ViigimaaAlla TikhazeElena Kumskova • Galina KonovalovaJelena AbinaGalina ZemtsovskayaTatyana Kotkina •

  2011cites this paper
• Composition and antioxidative activities of supercritical CO2-extracted oils from seeds and soft parts of northern berries

  2011cites this paper
• Oxidized LDL and the risk of coronary heart disease: results from the MONICA/KORA Augsburg Study.

  2011cites this paper
• Oxidized low-density lipoprotein.

  2010cites this paper
• Novel systemic cardiovascular disease biomarkers.

  2010cites this paper
• Postprandial metabolic events and fruit-derived phenolics: a review of the science

  2010cites this paper
• Reactive Oxygen Species Mediate Oxidized Low-Density Lipoprotein-Induced Inhibition of Oct-4 Expression and Endothelial Differentiation of Bone Marrow Stem Cells

  2010influential citation
• Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis

  2010cites this paper
• Interrelation between Malonyl Dialdehyde-Dependent Modification and Cholesterol Content in Low-Density Lipoproteins

  2010cites this paper
• Lipoprotein(a) and the risk of vascular disease

  2010cites this paper
• Potential restoration of HDL function with apolipoprotein A-I mimetic peptide in end-stage renal disease.

  2009cites this paper
• High-density lipoprotein cholesterol as a risk factor and target of therapy after acute coronary syndrome.

  2009cites this paper
• Effects of acute exercise on atherogenic lipids in untreated mild hypertensive patients.

  2009cites this paper